Safety Reporting for Sites
Home › Sites › Safety Reporting for Sites
Quorum Review IRB requires reporting of all events that may constitute unanticipated problems involving risk to research participants or others as well as new or updated safety information relating to a study or study product. Reportable events/information must be reported to Quorum within 10 business days of their occurrence. Reportable events include:
- Serious Adverse Events
- Major Protocol Deviations/Violations
- Research participant complaints
- Adverse audit or enforcement actions (e.g., Form FDA 483, FDA Warning Letters, FDA Establishment Inspection Reports (EIRs), adverse Sponsor audit findings, etc.)
- IND Safety Reports that qualify as Unanticipated Problems
- New/updated safety information that may increase risk to participants
- Reports, publications, or interim results or findings
- Recalls, Withdrawals, or Clinical Holds
- Any other incident that could qualify as an Unanticipated Problem
- Any incident that must be reported according to the policies of the sponsor or site
If your sponsor’s safety submission requirements are different than Quorum’s you may submit the event to Quorum regardless and we will respond with a standard acknowledgement.
For additional guidelines (including examples) regarding the types of incidents that require prompt reporting, see the "Safety Information and Unanticipated Problems Reporting Guidelines" in the forms tab.
Required
F-018 - Protocol Deviation (Major) /Violation Report
Use this form for reporting Major Protocol Deviations / Violations.
F-022 - Serious Adverse Event Report
Use this form for all Serious Adverse Events that occur at the Principal Investigator's site.
F-024 - Unanticipated Problem Report
Use this form for all Unanticipated Problems meeting Quorum Review's reporting requirements that occur at the Principal Investigator's research site.
F-035 - Prospective Protocol Waiver/Exception Request Form
Use this form to request Board review of prospective Protocol Waivers / Exceptions. You must receive Board approval before initiating any change to the research.
F-021 - Safety Information and Unanticipated Problem Cover Page
Use this form for all Safety Information and Unanticipated Problems that occur external to the PI's site and meet Quorum reporting requirements
Guidance
G-036 - Safety Information and Unanticipated Problems Guidelines
This guidance document provides a listing of the safety events that could be reported to Quorum, examples of the events, reporting criteria, and what forms to use to report the events to Quorum.
G-042 - Safety and Unanticipated Problems Powerpoint
Powerpoint presentation on when, and how, to report safety information to Quorum Review.
G-043 - Handbook for Quorum Review IRB (Requires an OnQ Portal Account)
The Handbook provides a guide for using Quorum Review IRB as an ethics review board. It contains policies, procedures, and guidelines to be used in preparing materials for Board review, as well as information on managing ongoing research activities, continuing and periodic review, and closing.
A reportable event can occur in either a clinical setting (such as a serious and unanticipated reaction to the study drug) or a non-clinical setting (such as the loss of a laptop with study data). The event is reportable if it poses risk to research participants, research staff, or others and is possibly related to the study.
It is ultimately the decision of the Board whether a reportable event constitutes an Unanticipated Problem. In the U.S., Quorum is required to report a Board determination of an Unanticipated Problem to the FDA, OHRP or other appropriate oversight agency.
- Serious adverse events
- Major protocol deviations/violations
- Research participant complaints
- Adverse audit or enforcement actions (e.g., Form FDA 483, FDA Warning Letters, FDA Establishment Inspection Reports (EIRs), adverse Sponsor audit findings, etc.)
- IND Safety Reports that qualify as unanticipated problems involving risk to participants or others
- New/updated safety information that may increase risk to participants
- Reports, publications, or interim results or findings
- Recalls, wthdrawals, or clinical holds
- Any other incident that could qualify as an unanticipated problem involving risk to participants or others, such as the loss of a laptop with confidential study data (more examples below)
- Any incident that must be reported according to the policies of the sponsor or site
For additional guidelines regarding the types of incidents that require prompt reporting, refer to the Safety Information and Unanticipated Problems Reporting Guidelines.
- Serious;
- Unanticipated; and
- Related to the study product or study procedures.
If an adverse event meets all three requirements, it is a reportable SAE. An "unanticipated" adverse event is one that is not identified in nature, severity, or frequency in the relevant safety documents(s) for the study product or is not identified as a possible risk in the study protocol or the informed consent form for the study. Investigators must report an SAE to Quorum Review IRB within ten (10) business days of becoming aware of the event’s occurrence. Please use Quorum Review IRB’s Serious Adverse Event Report form.
An adverse event that does not meet all three requirements is not an SAE and does not need to be reported to Quorum Review IRB. Quorum does not collect reports of adverse events that are not SAEs.
- Safety or welfare of research participants or others;
- Rights of research participants or others; or
- Integrity of the study design
Investigators must report a major protocol deviation to Quorum Review IRB within ten (10) business days of becoming aware of the event’s occurrence. Please use Quorum Review IRB’s Major Protocol Deviation Report form.
- Failure to obtain informed consent
- Informed consent obtained after the initiation of study procedures
- Omitting study procedure(s) required by approved protocol
- Performing a study procedure that is not outlined in the IRB-approved protocol
- Failure to report a serious adverse event
- Drug dispensing/dosing error
- Failure to securely control the study product
- Enrolling participants outside of inclusion criteria
- Failure to follow a Safety Monitoring plan
- Study visit outside of window, only if in the opinion of the investigator, if affects the safety or welfare of the research participants or others, the rights or participants or other or the integrity of the study design.
- Use of an unapproved consent form
- Study procedure conducted out of timeframe
- Study visit out of timeframe
- Participant failure to initial every page of the consent form
- Copy of consent form not given to participant during informed consent process
- Site over-enrollment
- Participant failure to return diary
- Missing original signed consent, but have a copy of the participant signed consent
Minor protocol violations do not need to be reported to Quorum Review IRB.
- Unresolved research participant complaints
- Adverse audit or enforcement actions
- Breaches of privacy/confidentiality
- Unauthorized use or disclosure of protected health information (PHI)
- Loss of study records
- Disappearance of study drug
- Research staff misconduct affecting the research
- Incarceration of a research participant
- Injury sustained by research staff relating to the study
- Suspension of principal investigator’s medical license
- Higher than expected volume of adverse events
- Higher than expected volume of protocol deviations
- Higher than expected volume of participant drop-out rates
- Complaint from a research participant involving an unanticipated risk that cannot be resolved by the research staff
- New findings that may influence a research participant’s willingness to continue participation in the study
- Adverse events that, in the investigator’s judgment, are not related to the study (such as a participant catching the flu);
- Adverse events that are anticipated or expected as part of the study (such as nausea in a trial of a chemotherapy drug);
- IND Safety Reports that, in the investigator’s judgment, do not adversely affect the conduct of the study at his/her research facility;
- Minor protocol deviations (such as study visits performed slightly out of window);
- Minor research participant complaints that are adequately resolved by the research staff.
The exception is that at the time of periodic (continuing) review, the Quorum Site Status Report asks the site whether the unreported adverse events, minor protocol deviations or other unanticipated problems experienced at the site over the course of the prior reporting period – when considered together - indicate that changes to the research plan or consent form should be made. If the site responds "yes", then Quorum asks that the site submit an analysis of the unreported events and a rationale for suggested changes to the study plan.
We understand that a number of sponsors and sites have SOPs that require transmission of all Reports to the Board regardless of the nature of the incident reported. If you are submitting a Report to fulfill such a requirement, you can so indicate on the cover page. You will receive an acknowledgment of receipt by Quorum.
For centralized multi-site studies, Quorum Review IRB requests that sponsors submit the following documents on behalf of the investigators:
- Investigator Brochures
- Package Inserts
- Device Manuals
Please note that standard acknowledgment represents receipt only; the standard acknowledgement does not represent Board review of the reported information. The Board will send a separate notice if it is determined upon review that additional action is necessary. In a multi-site study in which a number of investigators submit duplicate information (such as IND Safety Reports), Quorum will return a standard acknowledgment to each investigator who sends a submission.
